CORRECTION article

Front. Bioeng. Biotechnol., 12 November 2024

Sec. Tissue Engineering and Regenerative Medicine

Volume 12 - 2024 | https://doi.org/10.3389/fbioe.2024.1520130

Corrigendum: Microfluidic-based human prostate-cancer-on-chip

  • 1. Department of Aerospace and Mechanical Engineering, Tucson, AZ, United States

  • 2. Cancer Biology Graduate Interdisciplinary Program, Tucson, AZ, United States

  • 3. College of Sciences, Tucson, AZ, United States

  • 4. Department of Molecular and Cellular Biology, Tucson, AZ, United States

  • 5. University of Arizona Cancer Center, University of Arizona, Tucson, AZ, United States

In the published article, there was an error in the Funding statement. The Funding statement was incorrectly written as: “The author(s) declare financial support was received for the research, authorship, and/or publication of this article. LJ, HK, ST, TC, CM, and YZ were supported by funding from NIH/NCI MPI R01 CA254200 as part of the Tissue Engineering Consortium and TACMASR by P30 CA023075 UACC support grant. TC acknowledges partial support by the NIH/NCI U54CA143924 for the Partnership of Native American Cancer Prevention (NACP).” The correct Funding statement appears below:

Statements

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. LJ, HK, ST, TC, CM, and YZ were supported by funding from NIH/NCI MPI R01 CA254200 as part of the Tissue Engineering Consortium and TACMASR by P30 CA023075 UACC support grant. TC acknowledges partial support by the NIH/NCI U54CA143924 for the Partnership of Native American Cancer Prevention (NACP). ST acknowledges support by NIH/NCI T32 CA009213.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

organ-on-chip, microfluidics, prostate cancer, stromal fibroblasts, cancer-associated fibroblasts (CAFs), prostate tumor invasion, tumor microenvironment

Citation

Jiang L, Khawaja H, Tahsin S, Clarkson TA, Miranti CK and Zohar Y (2024) Corrigendum: Microfluidic-based human prostate-cancer-on-chip. Front. Bioeng. Biotechnol. 12:1520130. doi: 10.3389/fbioe.2024.1520130

Received

30 October 2024

Accepted

01 November 2024

Published

12 November 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

12 - 2024

Updates

Copyright

*Correspondence: Linan Jiang,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics